Quince Therapeutics Inc.

NASDAQ: QNCX · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.62
-4.71%
After-hours: Aug 15, 2025, 07:43 PM EDT

Quince Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-56.83M -31.39M -51.66M -89.94M
Depreciation & Amortization
186K 322K 204K 344K
Stock-Based Compensation
4.75M 5.22M 16.62M 29.85M
Other Working Capital
-1.41M 2.27M -3.89M -5.62M
Other Non-Cash Items
20.48M 5.82M 913K 199K
Deferred Income Tax
n/a -248K -284K 878K
Change in Working Capital
-484K 1.98M -9.83M -4.26M
Operating Cash Flow
-31.9M -18.29M -44.04M -62.93M
Capital Expenditures
-257K -160K -133K -180K
Cash Acquisitions
n/a -2.12M 10.59M -58.95M
Purchase of Investments
-89.56M -113.78M -75.02M -38.79M
Sales Maturities Of Investments
109.38M 111.21M 82.49M 97.92M
Other Investing Acitivies
2.35M -910K 70K 58.95M
Investing Cash Flow
21.91M -5.76M 18M 58.95M
Debt Repayment
n/a -6K -49K n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5M n/a 148K n/a
Financial Cash Flow
-4.78M 143K 707K 6.81M
Net Cash Flow
-14.54M -23.83M -25.14M 2.88M
Free Cash Flow
-32.16M -18.45M -44.17M -63.11M